Is There a Therapeutic Window for Metabolism-Based Cancer Therapies?
作者信息
Fendt Sarah-Maria
机构信息
Laboratory of Cellular Metabolism and Metabolic Regulation, VIB Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
出版信息
Front Endocrinol (Lausanne). 2017 Jul 4;8:150. doi: 10.3389/fendo.2017.00150. eCollection 2017.
Abstract
摘要
相似文献
1
Is There a Therapeutic Window for Metabolism-Based Cancer Therapies?
Front Endocrinol (Lausanne). 2017 Jul 4;8:150. doi: 10.3389/fendo.2017.00150. eCollection 2017.
2
Endothelial cells and cancer cells: metabolic partners in crime?
Curr Opin Hematol. 2015 May;22(3):234-42. doi: 10.1097/MOH.0000000000000138.
3
Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
Int J Cancer. 2014 Sep 15;135(6):1319-29. doi: 10.1002/ijc.28787. Epub 2014 Mar 3.
4
Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
Clin Cancer Res. 2010 Feb 15;16(4):1191-205. doi: 10.1158/1078-0432.CCR-09-1634. Epub 2010 Feb 9.
5
The penumbra, therapeutic time window and acute ischaemic stroke.
Baillieres Clin Neurol. 1995 Aug;4(2):279-95.
6
Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Clin Cancer Res. 2005 Apr 1;11(7):2651-61. doi: 10.1158/1078-0432.CCR-04-1564.
7
Selectins promote tumor metastasis.
Semin Cancer Biol. 2010 Jun;20(3):169-77. doi: 10.1016/j.semcancer.2010.04.005. Epub 2010 May 7.
8
Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil.
Oncotarget. 2015 Nov 3;6(34):35157-72. doi: 10.18632/oncotarget.6038.
9
Cancer immunologists and cancer biologists: why we didn't talk then but need to now.
Cancer Res. 2007 Apr 15;67(8):3500-4. doi: 10.1158/0008-5472.CAN-06-4626. Epub 2007 Apr 5.
10
Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
Biochim Biophys Acta. 2013 Dec;1836(2):273-86. doi: 10.1016/j.bbcan.2013.08.001. Epub 2013 Aug 8.
引用本文的文献
1
Identifying metabolic limitations in the tumor microenvironment.
Sci Adv. 2024 Oct 4;10(40):eadq7305. doi: 10.1126/sciadv.adq7305. Epub 2024 Oct 2.
2
Effects of metabolic cancer therapy on tumor microenvironment.
Front Oncol. 2022 Dec 13;12:1046630. doi: 10.3389/fonc.2022.1046630. eCollection 2022.
3
Efforts in Bioprospecting Research: A Survey of Novel Anticancer Phytochemicals Reported in the Last Decade.
Molecules. 2022 Nov 28;27(23):8307. doi: 10.3390/molecules27238307.
4
A Microphysiological Cell-Culturing System for Pharmacokinetic Drug Exposure and High-Resolution Imaging of Arrays of 3D Microtissues.
Front Pharmacol. 2021 Dec 21;12:785851. doi: 10.3389/fphar.2021.785851. eCollection 2021.
5
Unravelling the Anticancer Mechanisms of Traditional Herbal Medicines with Metabolomics.
Molecules. 2021 Oct 29;26(21):6541. doi: 10.3390/molecules26216541.
6
Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma.
J Biol Chem. 2021 Jan-Jun;296:100283. doi: 10.1016/j.jbc.2021.100283. Epub 2021 Jan 13.
7
screening for proline analog inhibitors of the proline cycle enzyme PYCR1.
J Biol Chem. 2020 Dec 25;295(52):18316-18327. doi: 10.1074/jbc.RA120.016106. Epub 2020 Oct 27.
8
Disruption of redox homeostasis for combinatorial drug efficacy in tumors as revealed by metabolic connectivity profiling.
Cancer Metab. 2020 Sep 29;8:22. doi: 10.1186/s40170-020-00227-4. eCollection 2020.
9
Defining a metabolic landscape of tumours: genome meets metabolism.
Br J Cancer. 2020 Jan;122(2):136-149. doi: 10.1038/s41416-019-0663-7. Epub 2019 Dec 10.
10
Determinants of nutrient limitation in cancer.
Crit Rev Biochem Mol Biol. 2019 Jun;54(3):193-207. doi: 10.1080/10409238.2019.1611733. Epub 2019 Jun 4.
本文引用的文献
1
Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity.
Immunity. 2017 May 16;46(5):714-729. doi: 10.1016/j.immuni.2017.04.016.
2
Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells.
Nat Commun. 2017 May 11;8:15267. doi: 10.1038/ncomms15267.
3
Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity.
Front Immunol. 2017 Mar 15;8:289. doi: 10.3389/fimmu.2017.00289. eCollection 2017.
4
Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.
Cancer Cell. 2016 Dec 12;30(6):968-985. doi: 10.1016/j.ccell.2016.10.006. Epub 2016 Nov 17.
5
Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors.
Metab Eng. 2017 Sep;43(Pt B):187-197. doi: 10.1016/j.ymben.2016.11.005. Epub 2016 Nov 12.
6
S-2-hydroxyglutarate regulates CD8 T-lymphocyte fate.
Nature. 2016 Dec 8;540(7632):236-241. doi: 10.1038/nature20165. Epub 2016 Oct 26.
7
Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis.
Cell Rep. 2016 Oct 11;17(3):837-848. doi: 10.1016/j.celrep.2016.09.042.
8
Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.
Science. 2016 Sep 9;353(6304):1161-5. doi: 10.1126/science.aaf5171.
9
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.
Expert Opin Biol Ther. 2016 Aug;16(8):1035-47. doi: 10.1080/14712598.2016.1185412. Epub 2016 May 19.
10
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis.
Cell Rep. 2016 Apr 19;15(3):574-587. doi: 10.1016/j.celrep.2016.03.043. Epub 2016 Apr 7.
Zotero 插件